Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It" ALT"Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who…

Continue ReadingLoxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It

Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free" ALT"Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple…

Continue ReadingInvestors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free

Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline" ALT"Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline"June 1, 2017By Alex Keown, BioSpace.com Breaking... Source: BioSpace

Continue ReadingMassachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline